Screener
CG Oncology CGON Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by CG Oncology in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The source filing: CG Oncology’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:45 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-336918
FAQ
- What is CG Oncology's total liabilities?
- CG Oncology (CGON) reported total liabilities of $56.54M in Q2 2026.
- How has CG Oncology's total liabilities changed year-over-year?
- CG Oncology's total liabilities increased by 81.9% year-over-year, from $31.09M to $56.54M.
- What is the long-term trend for CG Oncology's total liabilities?
- Over 2 years (2023 to 2025), CG Oncology's total liabilities has grown at a 63.9% compound annual growth rate (CAGR), from $14.51M to $38.99M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.
Ask your AI about CG Oncology's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude